140 related articles for article (PubMed ID: 36576589)
1. CACYBP knockdown inhibits progression of prostate cancer via p53.
Li Q; Liu Z; Ma L; Yin W; Zhang K
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5761-5772. PubMed ID: 36576589
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
[TBL] [Abstract][Full Text] [Related]
3. [Effect of p53-regulated apoptosis-inducing protein 1 transfection on the biological characteristics of PC-3M human prostate cancer cells].
Lin X; Zhao Q; Yin X; Tian R; Li F; Gao J; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):819-23. PubMed ID: 25108434
[TBL] [Abstract][Full Text] [Related]
4. [In vitro and in vivo inhibitory effect of Ad-ING4 gene on proliferation of human prostate cancer PC-3 cells].
Yang HC; Sheng WH; Xie YF; Miao JC; Wei WX; Yang JC
Ai Zheng; 2009 Nov; 28(11):1149-57. PubMed ID: 19895734
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis.
Fu C; Wan Y; Shi H; Gong Y; Wu Q; Yao Y; Niu M; Li Z; Xu K
J Cancer Res Clin Oncol; 2016 Apr; 142(4):741-8. PubMed ID: 26603518
[TBL] [Abstract][Full Text] [Related]
6. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer.
Ning X; Sun S; Hong L; Liang J; Liu L; Han S; Liu Z; Shi Y; Li Y; Gong W; Zhang S; Chen Y; Guo X; Cheng Y; Wu K; Fan D
Mol Cancer Res; 2007 Dec; 5(12):1254-62. PubMed ID: 18171983
[TBL] [Abstract][Full Text] [Related]
7. CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma.
Zhao M; Zhang RZ; Qi DW; Chen HY; Zhang GC
Exp Ther Med; 2020 Aug; 20(2):1397-1404. PubMed ID: 32742374
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
9. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
10. [CacyBP promotes the proliferation and invasion of non-small cell lung cancer].
Xu YJ; Hu YM; Qin C; Wang F; Cao W; Yu YW; Zhao L; Li J; Chen WQ; Li N; He J
Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):924-931. PubMed ID: 34530574
[No Abstract] [Full Text] [Related]
11. MTSS1 hypermethylation is associated with prostate cancer progression.
Chen J; Huang L; Zhu Q; Wang Z; Tang Z
J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
[TBL] [Abstract][Full Text] [Related]
12. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
[TBL] [Abstract][Full Text] [Related]
13. CacyBP/SIP protein reduces p53 stability by enhancing Mdm2 activity in p53 mutant glioma cells.
Qian F; Tang T; Wang S; Wang B; Wang L; Shi H
Neoplasma; 2021 Jan; 68(1):119-125. PubMed ID: 32880469
[TBL] [Abstract][Full Text] [Related]
14. CACYBP Enhances Cytoplasmic Retention of P27
Lian YF; Huang YL; Zhang YJ; Chen DM; Wang JL; Wei H; Bi YH; Jiang ZW; Li P; Chen MS; Huang YH
Theranostics; 2019; 9(26):8392-8408. PubMed ID: 31754404
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CRNDE regulates the growth and migration of prostate cancer cells by targeting microRNA-146a-5p.
Fu D; Zang L; Li Z; Fan C; Jiang H; Men T
Bioengineered; 2021 Dec; 12(1):2469-2479. PubMed ID: 34232111
[TBL] [Abstract][Full Text] [Related]
16. Imatinib mesylate inhibits androgen-independent PC-3 cell viability, proliferation, migration, and tumor growth by targeting platelet-derived growth factor receptor-α.
Nayeem MJ; Yamamura A; Hayashi H; Muramatsu H; Nakamura K; Sassa N; Sato M
Life Sci; 2022 Jan; 288():120171. PubMed ID: 34822800
[TBL] [Abstract][Full Text] [Related]
17. CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells.
Chen X; Mo P; Li X; Zheng P; Zhao L; Xue Z; Ren G; Han G; Wang X; Fan D
Mol Carcinog; 2011 Oct; 50(10):804-10. PubMed ID: 21268134
[TBL] [Abstract][Full Text] [Related]
18. S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis.
Ning X; Sun S; Zhang K; Liang J; Chuai Y; Li Y; Wang X
PLoS One; 2012; 7(1):e30185. PubMed ID: 22295074
[TBL] [Abstract][Full Text] [Related]
19. CacyBP/SIP nuclear translocation induced by gastrin promotes gastric cancer cell proliferation.
Zhai HH; Meng J; Wang JB; Liu ZX; Li YF; Feng SS
World J Gastroenterol; 2014 Aug; 20(29):10062-70. PubMed ID: 25110433
[TBL] [Abstract][Full Text] [Related]
20. Splicing factor arginine/serine-rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome-based cellular communication.
Zhang Y; Yu X; Sun R; Min J; Tang X; Lin Z; Xie S; Li X; Lu S; Tian Z; Gu C; Teng L; Yang Y
Clin Transl Med; 2022 Feb; 12(2):e684. PubMed ID: 35184390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
